| |
| |
|
| Insider
Information: |
Creech Timothy J |
| Relationship: |
See Remarks |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
19,462 |
|
|
Indirect Shares
|
2,493 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,955 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
Vice President of Fina... |
2004-06-22 |
19,462 |
2004-06-22 |
2,493 |
Premium* |
|
|
Salix Pharmaceuticals Ltd |
SLXP |
See Remarks |
2015-04-01 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
See Remarks |
• – – |
2015-04-01 |
4 |
D |
$173.00 |
$3,697,356 |
D/D |
(21,372) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
See Remarks |
• – – |
2015-04-01 |
4 |
D |
$173.00 |
$703,245 |
D/D |
(4,065) |
0 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
See Remarks |
• – – |
2015-03-06 |
4 |
S |
$157.67 |
$725,269 |
D/D |
(4,600) |
25,437 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
See Remarks |
• – – |
2015-01-02 |
4 |
D |
$114.94 |
$373,325 |
D/D |
(3,248) |
30,537 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
officerTitle |
• – – |
2003-07-24 |
4 |
S |
$47.00 |
$140,483 |
D/D |
(2,989) |
12,662 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Vice President of Finance |
• – – |
2003-10-20 |
4 |
S |
$25.75 |
$64,375 |
D/D |
(2,500) |
10,162 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Vice President of Finance |
• – – |
2003-10-20 |
4 |
OE |
$8.00 |
$20,000 |
D/D |
2,500 |
12,462 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Vice President of Finance |
• – – |
2003-10-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
200 |
9,962 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Vice President of Finance |
• – – |
2004-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
7,000 |
19,462 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
See Remarks |
• – – |
2015-03-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
30,037 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
See RemarksOfficer |
• – – |
2014-11-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,785 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
